Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas
- 23 December 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 118 (3) , 443-453
- https://doi.org/10.1007/s10549-008-0267-z
Abstract
Estrogen receptor α (ERα) activity is regulated by phosphorylation at several sites. Recently several antibodies specific for individual phosphorylated sites within ERα have became available. Such antibodies potentially provide invaluable tools to gain insight into the relevance in vivo of phosphorylated ERα in human breast tumors. However, validation of these antibodies for immunohistochemistry in particular is necessary in the first instance. In this study we have investigated the usefulness of several antibodies generated to specific phosphorylated sites within ERα for immunohistochemistry of formalin-fixed, paraffin-embedded human breast cancer biopsy samples. As well, these data demonstrate for the first time, the detection of multiple phosphorylated ERα forms in breast cancer (P-S104/106-ERα, P-S118-ERα, P-S167-ERα, P-S282-ERα, P-S294-ERα, P-T311-ERα, and P-S559-ERα) suggesting the possibility that profiling of phosphorylated ERα isoforms might be useful in selecting subgroups of breast cancer patients that would benefit from endocrine therapy.Keywords
This publication has 25 references indexed in Scilit:
- Identification of four novel phosphorylation sites in estrogen receptor α: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2BMC Biochemistry, 2009
- Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacyAnnals of Oncology, 2008
- Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase InteractionsMolecular and Cellular Biology, 2007
- Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumoursBritish Journal of Cancer, 2006
- Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifenEuropean Journal Of Cancer, 2006
- Application of Phosphorylation Site-Specific Antibodies to Measure Nuclear Receptor Signaling: Characterization of Novel Phosphoantibodies for Estrogen Receptor αNuclear Receptor Signaling, 2006
- The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast CancerCancer Research, 2005
- Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerEndocrine-Related Cancer, 2005
- Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with TamoxifenClinical Cancer Research, 2004
- Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor PhosphorylationMolecular and Cellular Biology, 2002